(Q51358753)

4 April 2018

reason for preferred rank

title

Pecazine (“Pacatal”) Compared with Amylobarbitone Sodium in Anxiety States (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.105.441.1064

3 March 2024

Pecazine ("pacatal") compared with amylobarbitone sodium in anxiety states (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14437895

3 March 2024

author name string

ROBIN AA

1

1 reference

4 April 2018

A. A. ROBIN

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14437895

3 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14437895

3 March 2024

publication date

1 October 1959

1 reference

4 April 2018

full work available at URL

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0368315X00045527

1 reference

https://api.crossref.org/works/10.1192/BJP.105.441.1064

The Journal of Mental Science

3 March 2024

published in

1 reference

4 April 2018

volume

105

1 reference

4 April 2018

page(s)

1064-1069

1 reference

4 April 2018

Treatment of schizophrenia pacatal and chlorpromazine compared.

cites work

1

1 reference

https://api.crossref.org/works/10.1192/BJP.105.441.1064

Effects of pacatal on symptoms in chronic psychotic female in-patients.

3 March 2024

4

1 reference

https://api.crossref.org/works/10.1192/BJP.105.441.1064

A Controlled Study of the Effect of Mephenesin on Psychiatric Out-Patients

3 March 2024

5

1 reference

https://api.crossref.org/works/10.1192/BJP.105.441.1064

Reserpine in the treatment of anxious and depressed patients

3 March 2024

7

1 reference

https://api.crossref.org/works/10.1192/BJP.105.441.1064

3 March 2024

Identifiers

1 reference

4 April 2018

1 reference

4 April 2018